Related Experiment Videos
Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction
1State University of New York, Buffalo Medical School, New York, USA.
Journal of Sex & Marital Therapy
|July 22, 1998
Summary
Sexual dysfunction from serotonin reuptake inhibitors (SRIs) is common, but spontaneous improvement is rare. A study of 132 trials found only 9.8% showed accommodation to this side effect, suggesting it
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SRIs) are widely prescribed antidepressants.
- Sexual dysfunction is a frequent and distressing side effect of SRI treatment.
- The potential for spontaneous remission or accommodation to SRI-induced sexual dysfunction is not well-established.
Purpose of the Study:
- To investigate the phenomenon of accommodation to serotonin reuptake inhibitor-induced sexual dysfunction.
- To quantify the rate of spontaneous remission of sexual side effects in patients taking SRIs.
Main Methods:
- A meta-analysis of 132 medication trials involving 97 patients was conducted.
- Data on the occurrence and duration of sexual dysfunction during SRI treatment were extracted and analyzed.
Main Results:
- Accommodation to SRI-induced sexual dysfunction was observed in only 9.8% of the analyzed medication trials.
- This suggests that spontaneous remission of sexual dysfunction is an uncommon outcome for patients on SRIs.
Conclusions:
- Clinicians should be aware that accommodation to SRI-induced sexual dysfunction is a rare event.
- Waiting for spontaneous remission may not be an effective strategy for managing this common side effect.
- Further research into effective management strategies for SRI-induced sexual dysfunction is warranted.